Localization of IFN-γ-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells

被引:19
作者
Connett, JM
Hunt, SR
Hickerson, SM
Wu, SJ
Doherty, GM [1 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[2] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
关键词
D O I
10.1089/107999003322558755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present work was to evaluate the induction and localization of Stat1, interferon (IFN) regulatory factor-1 (IRF-1), and IRF-2 after IFN-gamma exposure of human breast cancer cell lines, SKBR3, MDA468, MCF7, and BT20. Results from growth assays, Western staining, electrophoretic mobility shift assay (EMSA), and immunohistochemical. staining were collated to test our hypothesis that immunohistochemical analysis of Stat1, IRF-1, and IRF-2 would provide additional information about the functionality of the IFN-gamma signaling pathway in human tumor lines. EMSA results showed that in each of four cell lines, Stat1 expression was increased and demonstrated functional activity after IFN-gamma stimulation. Western and EMSA analysis showed upregulation of IRF-1 but not IRF-2 in each cell line. Confocal microscopy of cells stained for Stat1, IRF-1, and IRF-2 confirmed the results and also provided novel information about the intracellular localization of proteins and intercellular variations in responses. The proportion of cells with IRF-1 stimulation and translocation was positively correlated with the IFN-gamma growth suppression in vitro. In conclusion, using four independent assays, we have demonstrated that heterogeneity in IFN-gamma-mediated upregulation of signal transduction proteins can be detected in vitro and that these differences can explain distinct cellular growth effects.
引用
收藏
页码:621 / 630
页数:10
相关论文
共 21 条
[1]  
BOYOLENTA C, 1998, J IMMUNOL, V160, P911
[2]   ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS [J].
DIGHE, AS ;
RICHARDS, E ;
OLD, LJ ;
SCHREIBER, RD .
IMMUNITY, 1994, 1 (06) :447-456
[3]  
Doherty Gerard M., 1995, Surgical Forum, V46, P544
[4]   Interferon regulatory factor expression in human breast cancer [J].
Doherty, GM ;
Goucher, L ;
Sorenson, K ;
Lowney, J .
ANNALS OF SURGERY, 2001, 233 (05) :623-628
[5]   Endogenous interferon-gamma acts directly on tumor cells in vivo to suppress growth [J].
Doherty, GM ;
Tsung, K ;
McCluskey, B ;
Norton, JA .
JOURNAL OF SURGICAL RESEARCH, 1996, 64 (01) :68-74
[6]   INTERFERON-BETA GENE-REGULATION - TANDEMLY REPEATED SEQUENCES OF A SYNTHETIC 6-BP OLIGOMER FUNCTION AS A VIRUS-INDUCIBLE ENHANCER [J].
FUJITA, T ;
SHIBUYA, H ;
HOTTA, H ;
YAMANISHI, K ;
TANIGUCHI, T .
CELL, 1987, 49 (03) :357-367
[7]   ANTI-ONCOGENIC AND ONCOGENIC POTENTIALS OF INTERFERON REGULATORY FACTOR-I AND FACTOR-II [J].
HARADA, H ;
KITAGAWA, M ;
TANAKA, N ;
YAMAMOTO, H ;
HARADA, K ;
ISHIHARA, M ;
TANIGUCHI, T .
SCIENCE, 1993, 259 (5097) :971-974
[8]   ABSENCE OF THE TYPE-I IFN SYSTEM IN EC CELLS - TRANSCRIPTIONAL ACTIVATOR (IRF-1) AND REPRESSOR (IRF-2) GENES ARE DEVELOPMENTALLY REGULATED [J].
HARADA, H ;
WILLISON, K ;
SAKAKIBARA, J ;
MIYAMOTO, M ;
FUJITA, T ;
TANIGUCHI, T .
CELL, 1990, 63 (02) :303-312
[9]   STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES [J].
HARADA, H ;
FUJITA, T ;
MIYAMOTO, M ;
KIMURA, Y ;
MARUYAMA, M ;
FURIA, A ;
MIYATA, T ;
TANIGUCHI, T .
CELL, 1989, 58 (04) :729-739
[10]   STRUCTURE AND REGULATION OF THE HUMAN INTERFERON REGULATORY FACTOR-1 (IRF-1) AND IRF-2 GENES - IMPLICATIONS FOR A GENE NETWORK IN THE INTERFERON SYSTEM [J].
HARADA, H ;
TAKAHASHI, E ;
ITOH, S ;
HARADA, K ;
HORI, TA ;
TANIGUCHI, T .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) :1500-1509